ALLISON TEAGUE: Open Payments
NPI 1932862208 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,554 in 72 payments from 16 companies in 2025. Trend: 2023 $831 · 2024 $1,429 · 2025 $1,554
Food & beverage: $1,387Education: $167
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 16 | $295 |
| ABBVIE INC. | 12 | $204 |
| Novartis Pharmaceuticals Corporation | 6 | $158 |
| Lilly USA, LLC | 3 | $136 |
| GENZYME CORPORATION | 6 | $132 |
| Janssen Biotech, Inc. | 4 | $130 |
| PFIZER INC. | 7 | $117 |
| Amgen Inc. | 5 | $107 |
| Organon LLC | 3 | $66 |
| Incyte Corporation | 3 | $60 |
Products named: DUPIXENT, RINVOQ, TREMFYA, CIBINQO, OTEZLA, SKYRIZI, Rhapsido, OPZELURA.
Industry payments across TX — which companies pay providers there.
